Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
BMC Cancer|March 1, 2017
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesionsHitoshi Inari, Nobuyasu Suganuma, Kae Kawachi, et al.
Surgical Case Reports|July 21, 2017
Non-functioning parathyroid carcinoma: a case reportNobuyasu Suganuma, Hiroyuki Iwasaki, Satoru Shimizu, et al.
Anticancer Research|April 25, 2023
Clinical Significance of Cancer Stem Cell Markers in Primary and Metastatic Tissues in Patients With Breast CancerTakashi Yamanaka, Takashi Oshima, Daisuke Murayama, et al.
Breast (Edinburgh, Scotland)|February 25, 2021
Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN studyTakashi Ishikawa, Kentaro Sakamaki, Kazutaka Narui, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 3, 2019
Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapyMariko Asaoka, Kazutaka Narui, Nobuyasu Suganuma, et al.
Thyroid : Official Journal of the American Thyroid Association|August 4, 2016
The Safety and Efficacy of Weekly Paclitaxel Administration for Anaplastic Thyroid Cancer Patients: A Nationwide Prospective StudyNaoyoshi Onoda, Kiminori Sugino, Takuya Higashiyama, et al.
Cancers|March 4, 2020
Evaluation of the 8th Edition TNM Classification for Anaplastic Thyroid CarcinomaNaoyoshi Onoda, Iwao Sugitani, Ken-Ichi Ito, et al.
Biopreservation and Biobanking|April 30, 2021
Quality Control of Breast Cancer Surgery Samples: Introducing Time Stamp CheckingNobuyasu Suganuma, Kae Kawachi, Toshinari Yamashita, et al.
World Journal of Surgery|October 2, 2013
Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 casesKenichi Matsuzu, Kiminori Sugino, Katsuhiko Masudo, et al.
Cancers|August 27, 2021
Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)Eriko Tokunaga, Norikazu Masuda, Naohito Yamamoto, et al.
Pageof 8